Latest filing published 19 Sept 2022 for Tyra Biosciences, Inc., €11k.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Esther van den Boom: trading record in brief
Esther van den Boom, listed as finance chief, appears in our data through filings on Tyra Biosciences, Inc. shares, published by SEC (Form 4). We count 3 filings; the first trade dates from 17 September 2021 and the latest from 15 September 2022.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 19 September 2022 came the latest disclosure, a share grant for €11k in Tyra Biosciences, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Esther van den Boom
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,452 shares@ US$7.658544.3% of flowCommon StockSEC:0001209191-22-050613:0
- 1,800 shares@ US$8.525555.7% of flowCommon StockSEC:0001209191-22-049219:0
- 21,254 sharesCommon StockSEC:0000899243-21-036427:0
3 of 3 declarations
